HC
BMY icon

Hurley Capital’s Bristol-Myers Squibb BMY Stock Holding History

Hurley Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.04K Sell
116
-107
-48% -$6.24K ﹤0.01% 368
2025
Q4 		$12K Buy
223
+97
+77% +$4.67K 0.01% 308
2025
Q3 		$5.68K Buy
126
+10
+9% +$467 ﹤0.01% 426
2025
Q2 		$5.37K Hold
116
– – ﹤0.01% 363
2025
Q1 		$7.08K Hold
116
– – 0.01% 355
2024
Q4 		$7.13K Buy
+116
New +$6.48K 0.01% 314

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hurley Capital's BMY Position: Q1 2026 in Review

Hurley Capital reduced its Bristol-Myers Squibb (BMY) stake by 48% in Q1 2026, selling an estimated $6.24K and leaving 116 shares worth $7.04K. The position accounts for ﹤0.01% of the portfolio, ranked #368.

Hurley Capital first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $12K in Q4 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Hurley Capital held 116 shares of Bristol-Myers Squibb worth $7.04K as of Q1 2026.
  • Hurley Capital sold 107 Bristol-Myers Squibb shares in Q1 2026, an estimated $6.24K.
  • Bristol-Myers Squibb made up ﹤0.01% of Hurley Capital's portfolio in Q1 2026, its #368 holding.
  • Hurley Capital first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • Hurley Capital's Bristol-Myers Squibb position peaked at $12K in Q4 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Hurley Capital's 13F filing for Q1 2026, filed 6 May 2026.